Shareholder’s Council & Supervisory Board
Shareholder's Council
The Shareholder’s Council of Merz Pharma GmbH & Co. KGaA advises the Management Board; its duties include approving major projects, such as acquisitions and extraordinary transactions. The Shareholder’s Council has four members: two are appointed from the ranks of the Supervisory Board, and two others are members of the shareholder families.
Philip Burchard
Chairman of the Shareholders Council
- Chief Executive Officer of Merz since 2012
- Extensive experience in the pharmaceutical industry in Europe, Latin America and Asia
Dr. Christian Holzherr
- Chairman of the Supervisory Board, Member of the Shareholders’ Council and Chairman of the Tax and Audit Committee
- Long track record of CEO and CFO positions in the pharmaceutical and medical device industry
Christian Baatz
- Member of the shareholder families (fourth generation shareholder)
- Master’s degree in Business Administration
Andreas Meyer
- Member of the shareholder families (fourth generation shareholder)
- Business engineer
Supervisory Board
The Supervisory Board of Merz Pharma GmbH & Co. KGaA oversees the Management Board and is involved in decisions of major importance for the company. The following five members sit on the Supervisory Board:
- Dr. Christian Holzherr, Chairman of the Supervisory Board Merz Pharma GmbH & Co. KGaA
- Dr. Patricia Walker, Member of the Supervisory Board Merz Pharma GmbH & Co. KGaA
- Christian Baatz, Member of the Supervisory Board Merz Pharma GmbH & Co. KGaA
- Andreas Meyer, Member of the Supervisory Board Merz Pharma GmbH & Co. KGaA